20% Price Reduction on Diabetes Peptides!

We are pleased to announce a 20% price reduction on our Diabetes & Obesity peptide portfolio, effective immediately. This adjustment reflects our commitment to making high-quality peptides more accessible while continuing to deliver the reliability and expertise you have come to expect from JPT. 

Diabetes diagnostic and treatment research continues to advance rapidly, with peptides playing an increasingly important role in understanding glucose regulation, improving insulin analogues, and enabling novel therapeutic approaches. Researchers worldwide are leveraging peptide tools to accelerate discoveries in beta-cell function, hormone signaling, and metabolic control, and therefore, making accessible, high-quality peptides more valuable than ever! 

Is your peptide of choice not in our catalog? Take a look at our custom options! 

Contact us! If you are planning upcoming projects or would like a quote tailored to your needs, our team will be happy to support you. Kind regards, JPT Peptide Technologies GmbH